跳至主要内容
临床试验/NCT04532190
NCT04532190招募中不适用

Finding Alternatives to Standard Treatment for Attention-Deficit Hyperactivity Disorder

University of Calgary2 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2026年3月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
30
试验地点
2
主要终点
TEACH-2

研究概览

简要总结

Attention-Deficit/Hyperactivity Disorder (ADHD) is characterized by poor attention, impulsivity, hyperactivity and emotional-motivational dysregulation. Here, we will test if theta burst repetitive transcranial magnetic stimulation (rTMS) can reduce the symptoms of ADHD.

详细描述

Background & Rationale Attention-Deficit/Hyperactivity Disorder (ADHD) is characterized by poor attention, impulsivity, hyperactivity and emotional-motivational dysregulation. It has an estimated prevalence of 5% in children. Usually, ADHD in children is treated with stimulant medications, such as methylphenidate. However, these pharmacotherapy treatments have numerous unwanted side effects, including sleep disturbances, appetite changes, and emotional lability, and do not prove to be effective in every case.

A promising and alternative option for reducing ADHD symptoms is non-invasive brain stimulation. Repetitive transcranial magnetic stimulation (rTMS) is a form of non-invasive brain stimulation which involves the application of a magnetic field to the skull to change the behaviour and function of underlying brain areas. In turn, rTMS leads to positive long-term changes in neurochemical activity, and while studies are limited, some have shown that rTMS can reduce ADHD symptoms in adolescents with ADHD.

Methods Design: Open label TMS trial Primary Outcome: To examine the effect of active rTMS to the right prefrontal cortex on attention as measured by the TEACh-2

Outline:

  1. Baseline Assessment (MRI Scan, assessment scales, neuropsychological testing)
  2. rTMS intervention: 5 / week for 4 weeks.
  3. Post-intervention Assessment (MRI Scan, assessment scales, neuropsychological testing).

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None (Participant, Outcomes Assessor)

入排标准

年龄范围
9 Years 至 15 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of ADHD
  • 9-15 years old
  • IQ greater than 80
  • English fluency (to enable consent/assent)
  • If on medication, must have been on the same type and dosage for at least 3 months.

排除标准

  • Diagnosis of mania, psychosis, or bipolar disorder
  • Impediments to TMS or MRI (i.e. metal implants in body)
  • Prior electroconvulsive therapy or vagus nerve stimulation
  • Diagnosis of Autism Spectrum Disorder.

研究组 & 干预措施

Active rTMS

Experimental

Active repetitive TMS

干预措施: rTMS (Device)

结局指标

主要结局

TEACH-2

时间窗: Baseline to week 5

Test of everyday attention in children - 2. Direct assessment of attention abilities in children.

次要结局

  • SNAP-18(5 weeks and 52 weeks.)
  • PedsQL(Baseline to week 5)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Kara Murias

Assistant Professor

University of Calgary

研究点 (2)

Loading locations...

相似试验